North Dakota 2023-2024 Regular Session

North Dakota Senate Bill SB2093

Introduced
1/3/23  
Refer
1/3/23  
Report Pass
1/12/23  
Engrossed
1/17/23  
Refer
2/16/23  
Report Pass
3/14/23  
Enrolled
4/10/23  

Caption

The scheduling of controlled substances; and to declare an emergency.

Impact

If enacted, SB2093 would significantly impact the state's controlled substances laws by detailing specific criteria for scheduling drugs. The bill encompasses various classes of substances and aims to streamline how these are classified to ensure that law enforcement and healthcare professionals have clearer guidelines. This change is expected to enhance public safety by reducing the instances of misuse and illegal distribution of controlled substances, thus aiming to protect public health and safety in North Dakota.

Summary

Senate Bill No. 2093 was introduced in the North Dakota Legislative Assembly to amend and reenact sections of the North Dakota Century Code relating to the scheduling of controlled substances. This bill specifically targets the regulation of substances deemed to have potential for abuse and sets forth a structured approach for classifying various substances, including narcotics, depressants, and stimulants. The legislation is seen as a vital update to the state's regulatory framework to keep pace with new and emerging drugs that pose public health risks.

Sentiment

The sentiment around SB2093 appears generally supportive, with recognition of the importance of regulating controlled substances effectively. Lawmakers, particularly those from the judiciary committee, expressed an understanding of the necessity to adapt to current trends in substance abuse. However, some concerns were raised regarding the potential unintended consequences, such as the possibility of over-regulation that could limit access to legitimate medical uses of certain substances, particularly for patients who rely on them for treatment.

Contention

Notable points of contention regarding SB2093 arose primarily around the definitions and criteria set forth for classifying certain substances. There were discussions on how new synthetic substances would be managed within the existing scheduling frameworks, and whether the definitions might inadvertently criminalize substances used for legitimate medical or recreational purposes. This reflects an ongoing debate in the legislative assembly about balancing public health safety with individual freedoms and medical needs.

Companion Bills

No companion bills found.

Similar Bills

SD SB35

Modify substances listed on the controlled substances schedule and to declare an emergency.

ND SB2064

The scheduling of controlled substances; and to declare an emergency.

IN SB0209

Drug schedules.

IN SB0379

Drug schedules.

KS SB9

Adding tianeptine to schedule I of the uniform controlled substances act.

WV HB2854

Removing certain drugs from schedule one

WV HB3343

Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration